Literature DB >> 11032923

Kinetics of plasma platinum in a hemodialysis patient receiving repeated doses of cisplatin.

K Hirai1, O Ishiko, T Sumi, Y Kanaoka, S Ogita.   

Abstract

The pharmacokinetics of cisplatin were studied in a 46-year-old hemodialysis patient treated for uterine cancer with weekly cisplatin. Hemodialysis was performed immediately before, one-hour after, and two-hours after cisplatin administration for two consecutive cycles each. The concentrations of total and free platinum were measured. The decay curve of both total platinum and free platinum showed a biphasic pattern characterized by an alpha-phase and a beta-phase, the same as in non-hemodialysis patients. There were no differences between the individual cycles in the peak platinum concentration or the decay pattern. The plasma platinum concentration decreased to below detection limit 3 months after the final dose.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032923     DOI: 10.3892/or.7.6.1243

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  1 in total

1.  Simultaneous chemoradiation with cisplatin in a patient with recurrent cervical cancer undergoing hemodialysis: analysis of cisplatin concentrations in serum and dialysate and therapy-related acute toxicity.

Authors:  Simone Marnitz; Ralph Kettritz; Andreas Kahl; Silvia Lehenbauer-Dehm; Leonie Förster; Volker Budach; Christhardt Köhler
Journal:  Strahlenther Onkol       Date:  2011-11-25       Impact factor: 3.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.